Edwards Lifesciences Corporation
EW
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspā¦ read more
Healthcare
Medical Devices
25 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$78.26
Price+0.10%
$0.08
1Y
Price
Market Cap
$45.946b
Large
Price/Earnings 3y Avg5y Avg
32.7x
Premium
Premium
Financials Overview
Key metrics over the past few years+26.1%
EBITDA Margin+21.8%
Net Profit Margin+15.7%
Free Cash Flow MarginRevenue
$5.685b
+4.5%
1y CAGR+2.1%
3y CAGR+2.3%
5y CAGREarnings
$4.148b
-0.6%
1y CAGR+63.1%
3y CAGR+47.6%
5y CAGREPS
$6.96
-0.1%
1y CAGR+65.7%
3y CAGR+49.9%
5y CAGRBook Value
$10.607b
$13.489b
Assets$2.882b
Liabilities$702.600m
DebtDebt to Assets
5.2%
0.4x
Debt to EBITDAFree Cash Flow
$607.900m
+109.7%
1y CAGR+7.3%
3y CAGR-2.6%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company